je.st
news
CytRx Unveils Novel LADR (Linker Activated Drug Release) Technology Platform
2015-07-01 08:34:27| drugdiscoveryonline Home Page
CytRx Corporation (NASDAQ: CYTR), a biopharmaceutical research and development company specializing in oncology, today unveiled its proprietary LADR™ (Linker Activated Drug Release) technology platform, a discovery engine designed to leverage the Company's expertise in albumin biology and linker technology for the development of a new class of anti-cancer therapies
Tags: technology
release
drug
platform
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||